PSMA-targeting compounds and uses thereof
US-9776977-B2 · Oct 3, 2017 · US
PSMA targeted compounds and uses thereof
US11998620B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11998620-B2 |
| Application number | US-202318456931-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 28, 2023 |
| Priority date | Nov 9, 2021 |
| Publication date | Jun 4, 2024 |
| Grant date | Jun 4, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
PSMA targeted compounds, pharmaceutical compositions comprising these compounds, and methods for treating and detecting cancers in a subject are described herein.
First claim
Opening claim text (preview).
Having described the invention, we claim: 1. A compound having the formula of: or a pharmaceutically acceptable salt thereof, chelated to a radionuclide selected from 225 Ac, 226 Ac, 227 Th, 211 Bi, 212 Bi, 213 Bi, 203 Pb, 212 Pb, or 177 Lu.
Assignees
Inventors
Classifications
conjugates with a carrier being an organic compounds · CPC title
carboxylic acid carriers, fatty acids (amino acids A61K51/0406) · CPC title
General or multifunctional contrast agents, e.g. chelated agents · CPC title
Antineoplastic agents · CPC title
Heterocyclic compounds (A61K47/558 takes precedence) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11998620B2 cover?
- PSMA targeted compounds, pharmaceutical compositions comprising these compounds, and methods for treating and detecting cancers in a subject are described herein.
- Who is the assignee on this patent?
- Univ Case Western Reserve
- What technology area does this patent fall under?
- Primary CPC classification A61K51/0485. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).